U.S. Hepatitis Diagnostic Testing for 10 Markers, 2019-2023: Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures--Hospitals, Blood Banks, Commercial Labs

The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

     - Hospitals                                                                              
     - Commercial/Private Labs
     - Blood Banks
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.


I. Introduction
II. Hepatitis Worldwide Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 Classification
0 Transmission of Infection
0 Occupational Hazards
0 Acute Hepatitis
0 Diagnosis of Acute Infection
0 Chronic Hepatitis
0 HCV and Other Chronic Liver Diseases
0 Alcoholic Liver Disease
0 Hepatitis B Coinfection
0 Cirrhosis and Hepatocellular Carcinoma
0 Diagnostic Tests
0 Possible Indications for HCV RNA Testing
0 Conclusions and Future Direction
E. Hepatitis D
0 Historical Perspective
0 Epidemiology
0 HBV-HDV "Coinfection" vs. "Superinfection"
0 Methods of Detecting HDV
0 Prevention
F. Hepatitis E
0 Background
0 Prevalence of the Disease
0 Diagnostic Tests
0 Epidemiologic Serosurveys
0 Serologic Cross-Reactivity
G. Hepatitis G
0 Vaccines and Drugs

H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. USA: Market Size, Growth and Major Suppliers
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche

- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables


Major Companies Developing or Marketing Hepatitis Tests
U.S.A
HAV NAT Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A
HBV NAT Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
HBs Ag Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Hepatitis C Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Anti-HBc Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Anti-HBs Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Anti-HAV Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.S.A.
HBc Ag Test Volume and Diagnostics Sales Forecast
by Market Segment

U.S.A.
HBe Ag Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
ALT/SGPT Test Volume and Diagnostics Sales Forecast
by Market Segment
U.S.A.
Hepatitis Testing Market Diagnostics Sales
by Major Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales
by Major Supplier

U.S. Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing

USD 4850 View Report

U.S. Infectious Disease Testing Market for Over 100 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

LeadingMarketResearch.coms new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends;

USD 4850 View Report

Europe Hepatitis Diagnostics Test Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Europe Hepatitis Diagnostics Test market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by

USD 3000 View Report

North America Hepatitis Diagnostics Test Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Hepatitis Diagnostics Test market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available